ライフサイエンスコーパス: sleep latency

1 eep across nights and a shorter baseline REM sleep latency.

2 receptor, Rdl(A302S), specifically decreases sleep latency.

3 netics of GABA(A) receptor signaling dictate sleep latency.

4 leep apnea was demonstrated only for reduced sleep latency.

5 tonin synthesis, pupillary light reflex, and sleep latency.

6 ion was seen between Epworth scores and mean sleep latency.

7 uration and intensity of NREMS and prolonged sleep latency.

8 egions, increased sleep times, and shortened sleep latencies.

9 normal sleep latency (>10 minutes), moderate sleep latency (5 to 10 minutes), or severe sleep latency

10 mokers, current smokers had a longer initial sleep latency (5.4 minutes, 95% confidence interval (CI)

11 Moreover, the median daytime sleep latency after two nights of sleep with subatmosphe

12 Income was independently associated with sleep latency and efficiency.

13 Zolpidem prolongs IPSCs to decrease sleep latency and increase sleep time, effects that depe

14 In the phase II study, tasimelteon reduced sleep latency and increased sleep efficiency compared wi

15 ystemic administration of zolpidem shortened sleep latency and increased sleep time.

16 with placebo, modafinil decreased nighttime sleep latency and increased slow-wave sleep time in coca

17 and 25 nM of adenosine significantly reduced sleep latency and increased total sleep time.

18 s disrupted by methamphetamine by decreasing sleep latency and increasing sleep efficiency compared w

19 flies are resistant to the effects of CBZ on sleep latency and that mutant RDL(A302S) channels are re

20 zed by decreased total sleep time, increased sleep latency, and decreased sleep efficiency, without d

21 ariables-male sex, sleepiness, nocturnal REM sleep latency, and extent of oxygen desaturation-could r

22 period significantly reduced REM, shortened sleep latency, and increased EEG delta power in rats.

23 duction in plasma tryptophan concentrations, sleep latency, and REM latency, as well as increased REM

24 thanol microinjections significantly reduced sleep latency, and tended (P<0.06) to increase total sle

25 imination, delayed gastric emptying, altered sleep latency, anxiety-like behavior, and age-dependent

26 piness Scale), objective sleepiness (reduced sleep latency as determined by the Multiple Sleep Latenc

27 groups of patients who were defined by mean sleep latency as having normal sleep latency (>10 minute

28 s the opposite effect on sleep; it increases sleep latency as well as decreasing sleep.

29 afinil was associated with increased daytime sleep latency, as measured by the Multiple Sleep Latency

30 ystemic zolpidem administration also reduced sleep latency, but less so than for histamine neurons.

31 phically assessed (upper or lower quartiles) sleep latency, continuity, and duration (RRs = 2.2-4.7;

32 stress-induced insomnia in humans: increased sleep latency, decreased non-REM (nREM) and REM sleep, i

33 These experiments uncouple the regulation of sleep latency from that of sleep duration and suggest th

34 fined by mean sleep latency as having normal sleep latency (>10 minutes), moderate sleep latency (5 t

35 slow-wave sleep time, total sleep time, and sleep latency in cocaine-dependent and healthy participa

36 desensitization, underlies the regulation of sleep latency in flies.

37 naptic neuronal protein, was associated with sleep latency in the multiple sleep latency test.

38 with longer total sleep time and shorter REM sleep latency in the third week of abstinence.

39 TTX significantly shortened sleep latency, increased NREM time, decreased REM time,

40 ore and after sleep onset, such as prolonged sleep latency, loss of stage 3-4 sleep, reduced rapid ey

41 An MSLT mean sleep latency < or =8 min and > or =2 SOREMPs (diagnosti

42 e sleep latency (5 to 10 minutes), or severe sleep latency (<5 minutes) (analysis of variance, P = 0.

43 with an objective criterion for EDS: a mean sleep latency (MSL) < 10 min.

44 cy, sleep onset and rapid eye movement [REM] sleep latencies, non-REM and REM sleep stages, and wakef

45 hted effect sizes for subjective measures of sleep latency, number of awakenings, wake time after sle

46 Epworth Sleepiness Scale scores and mean sleep latency on the multiple sleep latency test.

47 ), a 5-min decrease in the MSLT-derived mean sleep latency (OR = 1.9, 95% CI = 1.3 to 2.8), a 90-min

48 s with Parkinson disease exhibited increased sleep latency (P = .04), reduced sleep efficiency (P = .

49 7601612 with polysomnographically determined sleep latency (P = 0.002).

50 ion was seen between Epworth scores and mean sleep latency (Pearson correlation, -0.17 [95% CI, -0.35

51 In many patients, a short rapid eye movement sleep latency (REML) during the NPSG is also observed bu

52 n ICU patients is characterized by prolonged sleep latencies, sleep fragmentation, decreased sleep ef

53 In the phase III study, tasimelteon improved sleep latency, sleep efficiency, and wake after sleep on

54 rsomnolence was quantified with the multiple sleep latency test (MSLT) and survival analysis was used

55 deficiency, is diagnosed using the Multiple Sleep Latency Test (MSLT) following nocturnal polysomnog

56 ent (REM) periods (2omSOREMPs) on a Multiple Sleep Latency Test (MSLT) raise the possibility of narco

57 The Multiple Sleep Latency Test (MSLT) remains an important diagnosti

58 ts with cataplexy but with a normal multiple sleep latency test (MSLT) result, or if MSLT is not inte

59 et REM periods (SOREMPs) during the Multiple Sleep Latency Test (MSLT).

60 tive sleepiness was assessed by the Multiple Sleep Latency Test in all subjects, problem sleepiness b

61 Sleepiness Scale and the objective multiple sleep latency test may evaluate different, complementary

62 The Multiple Sleep Latency Test was performed at 11:30 a.m., 2:00 p.m

63 sleep latency as determined by the Multiple Sleep Latency Test), and neurobehavioral functioning (la

64 rements included polysomnography, a multiple sleep latency test, an oral glucose tolerance test, dete

65 e sleep latency, as measured by the Multiple Sleep Latency Test, and a nearly significant decrease in

66 tory tests such as polysomnography, multiple sleep latency test, and actigraphy, along with referral

67 However, in a multiple sleep latency test, the cage change group showed signifi

68 ormed with the use of the nighttime Multiple Sleep Latency Test, the Clinical Global Impression of Ch

69 ssociated with sleep latency in the multiple sleep latency test.

70 t-day sleepiness as measured by the multiple sleep latency test.

71 ic leg movement; and results of the multiple sleep latency test.

72 cores and mean sleep latency on the multiple sleep latency test.

73 s 1.5 minutes +/- 39 seconds on the Multiple Sleep Latency Test.

74 me, 2 nights of polysomnography and multiple sleep latency tests in the laboratory, and body composit

75 age change group showed significantly longer sleep latencies than the gentle handling group, indicati

76 r therapy resulted in a greater reduction in sleep latency than pharmacotherapy.

77 ent from baseline in mean (+/-SEM) nighttime sleep latency (the interval between the time a person at

78 oring and sleep logs to measure time in bed, sleep latency (time required to fall asleep), sleep dura

79 at Weeks 1 and 4 (p < 0.001) and in multiple sleep latency times (MSLT) at Week 4 (p < 0.05).

80 sleep, and with increases in latency to REM sleep, latency to persistent sleep, and percent Stage 3/

81 The number of awakenings per hour of sleep, latency to sleep onset, and percent Stage 1 sleep

82 The mean sleep latency was 1.5 minutes +/- 39 seconds on the Mult

83 5 (standard deviation (SD), 1.2) hours, mean sleep latency was 21.9 (SD, 29.0) minutes, mean sleep du

84 Initial sleep latency was significantly longer in affected subje

85 In older people sleep latencies were longer close to the crest of the me

86 Sleep latencies were longest just before the onset of me

87 e the onset of melatonin secretion and short sleep latencies were observed close to the temperature n

88 eye movement (REM) sleep and shortened NREM sleep latency with a simultaneous decrease in core tempe